Have you been diagnosed with Hidradenitis Suppurativa (HS)?
Learn about a no-cost investigational treatment that may help control the symptoms of Hidradenitis Suppurativa, also known as acne inversa or Verneuil’s disease.
Do you struggle with moderate to severe Hidradenitis Suppurativa (HS)?
Hidradenitis Suppurativa (HS) is a chronic and often debilitating skin condition that commonly affects areas where skin touches skin, such as the armpits and groin. This painful condition leads to recurrent, draining nodules and abscesses that can become infected, significantly impacting daily life and emotional well-being.
If you have moderate to severe HS, you might qualify for a clinical research study evaluating an investigational oral medication taken once daily. This treatment aims to reduce the number of abscesses and nodules, alleviate inflammation, and prevent the disease from worsening.
The study is being conducted at select locations across the U.S. Eligible participants will receive all study-related care at no cost. Compensation for time and travel may also be available.
FILL OUT THE FORM BELOW IF YOU MEET THE FOLLOWING CRITERIA
- •Are between the ages of 18 to 70
- •Have a history of hidradenitis suppurativa (HS) for at least 12 months
- •Have tried oral antibiotics for at least one month
- •Are not pregnant, breastfeeding, or planning to become pregnant
About the Study
Hidradenitis Suppurativa (HS) is known for causing chronic pain, drainage, and odor, significantly impacting quality of life. Effective management of HS often involves a combination of treatments, including medication and lifestyle changes to help control symptoms.
This clinical research study lasts approximately 24 weeks and involves taking an investigational oral medication daily. This mediation could potentially lessen HS symptoms, treat painful lesions, minimize drainage, decrease recurrence and inflammation, and slow disease progression.
Participation is at no cost and includes all study-related medical examinations, ECGs, laboratory work, and various evaluations conducted by medical investigators. Additionally, you may receive compensation for the time and travel required to participate.
Why Participate?
If you have Hidradenitis Suppurativa (HS), you could qualify for a new clinical research study. This study is evaluating an investigational oral medication designed to treat existing skin lesions, alleviate pain, and reduce inflammation associated with HS.
If you qualify, you will receive:
No-cost Study Care
You will receive study-related care from experienced doctors, nurses, and research staff.
Exams
The study will include physical examinations, ECGs, laboratory work, and other examination visits with a trained investigator.
Compensation
You might be eligible to receive compensation for your time and travel.
Chat With a Research Coordinator
Fill out the form below to determine if you are eligible. If you meet the initial criteria, a research team member from a location near you will contact you. If you don’t qualify now, please still submit the form. The study criteria may change, and you could become eligible then.
© 2025 Accelerate Recruitment | Privacy Policy | Legal Notice
